Newest
-
UNESCO Intangible Cultural Heritage Spring Festival Debuts in Greece, Presented by Beijing Municipal Culture and Tourism Bureau
-
SOUEAST Unveiled in Dubai: A Bold Step Into the Middle East
-
Scale Technology: Reshaping the path of wealth growth in the next ten years
-
National Grid Pingxiang Power Supply Company: Power empowerment lighting up the way for "Chinese fireworks" to take off
News
-
UNESCO Intangible Cultural Heritage Spring Festival Debuts in Greece, Presented by Beijing Municipal Culture and Tourism Bureau
BeiJing , China - With the departure of the auspicious dragon, the golden snake arrives in spring. From song and dance performances to collaborative shows, from photography exhibitions to intangible cultural heritage experiences, this event marks the first time that the Spring Festival, now inscribed on UNESCO's Representative List of the Intangible Cultural Heritage of Humanity, is celebrated in Greece as an intangible cultural heritage event. Sponsored by the Beijing Municipal Culture and Tourism Bureau, the Chinese Embassy in Greece, and the Piraeus City Government, and organized by the Bei
01-28
Details -
SOUEAST Unveiled in Dubai: A Bold Step Into the Middle East
Dubai, United Arab Emirates - January 18, 2025 - SOUEAST celebrated a successful brand and model launch at Dubai’s iconic Burj Al Arab, the world’s first seven-star hotel. Attended by over 250 distinguished guests, including esteemed representatives, SOUEAST executives, and leaders from Elite Group Holding, the event marks the brand’s bold step into the Middle East auto market.
01-28
Details -
Scale Technology: Reshaping the path of wealth growth in the next ten years
In the era of rapid development of financial technology, Scale Technology is charting a new wealth growth path for investors with its innovative technology and strategic layout. Scale is not only committed to becoming a leader in quantitative trading, but also focusing on the next ten years to provide global investors with a more efficient, transparent and sustainable investment platform through technological innovation and global layout.
01-28
Details -
Antennova Presents Latest Phase I/II Data on ATN-022 in Advanced/Metastatic Gastric Cancer, Including an ORR of 42.9%, at ASCO GI 2025
BOSTON,Jan. 22,2025-- Antennova,a clinical-stage biotech company focused on oncology today announced the presentation of latest data from itsPhase I/II CLINCH study ongoing in China and Australia eval
01-26
Details -
New Reeracoen Workforce Report Underscores FWAs and Transparent Compensation as the Future
97.8% of Q4 2024 survey respondents are aware of flexible work arrangement policies,while most expect merit-based salary increases and bonuses
01-26
Details -
XAG and Chia Tai Present Smart Agriculture Solutions to Enhance the Capabilities of Thai Farmers
KANCHANABURI,Thailand,Jan. 22,2025-- XAG made a noteworthy debut at the 10th Chia Tai Fair,showcasing a comprehensive suite of smart agriculture solutions,including the autonomous drones,autopilot con
01-26
Details -
PCX Markets Earns B Corp Certification
SINGAPORE,Jan. 22,2025--PCX Markets,a marketplace for audited,traceable plastic waste recovery and responsible processing,today announced that it has been certified as a B Corporation™ (B Corp™),fu
01-26
Details -
Bright Scholar Schedules Unaudited Financial Results for the First Quarter of Fiscal 2025 Ended November 30, 2024
CAMBRIDGE,England and FOSHAN,China,Jan. 23,2025-- Bright Scholar Education Holdings Limited ("Bright Scholar," the "Company," "we" or "our") (NYSE: BEDU),a glob
01-26
Details -
Nuvoton Releases 1.7 W 420 nm Indigo Laser Diode
KYOTO,Japan,Jan. 23,2025-- Nuvoton Technology Corporation Japan (hereinafter "NTCJ") announced on January 15 the launch of its industry-leading (*) indigo semiconductor laser,which emits an
01-26
Details -
Kelun-Biotech's Product Tagitanlimab Approved for Marketing in Second Indication in Combination with Cisplatin and Gemcitabine For the First-line Treatment of Patients with recurrent or metastatic NPC
CHENGDU,China,Jan. 23,2025--Sichuan Kelun-Biotech Biopharmaceutical Co.,Ltd. (the "Company") announced that the Company received marketing authorization in China from National Medical Produc
01-26
Details